Penn Nursing’s Alison Buttenheim, PhD, MBA, Appointed to NAM COVID Vaccine Committee
The goal of the ad hoc committee on Equitable Allocation of Vaccine for the Novel Coronavirus is to develop an overarching framework for vaccine allocation to assist policymakers in the domestic and global health communities in planning for equitable allocation of vaccines against COVID-19.
Buttenheim, the Patricia Bleznak Silverstein and the Howard A. Silverstein Term Endowed Professorship in Global Women’s Health in Penn Nursing’s Department of Family & Community Health, is a social scientist and public health researcher, who is widely recognized as an expert in the field of vaccine acceptance and vaccine exemption policy. In her work in the US and in Indonesia, Laos, Peru, and South Africa, she designs and evaluates trial interventions to improve uptake of evidence-based infectious disease prevention programs.
Buttenheim is also an Assistant Professor of Health Policy in Penn’s Perelman School of Medicine; a Senior Fellow in the Leonard Davis Institute of Health Economics; an Associate Director of the Center for Health Incentives and Behavioral Economics; and an Associate Director of the National Clinician Scholars Program.